Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Revenues:
Product sales	$ 1,423.2		$ 1,308.1
Royalties	62.8		32.3
Other revenues	2.4		6.4
Total revenues	1,488.4		1,346.8
Costs and expenses:
Cost of product sales	227.8		229.5
Research and development	193.7	[1]	360.5	[1]
Selling, general and administrative	506.6	[1]	430.3	[1]
Gain on sale of product rights	(5.2)		(36.4)
Reorganization costs	15.2		49.4
Integration and acquisition costs	75.7		6.6
Total operating expenses	1,013.8		1,039.9
Operating income from continuing operations	474.6		306.9
Interest income	2.0		0.5
Interest expense	(9.6)		(7.8)
Other income, net	4.3		4.7
Total other expense, net	(3.3)		(2.6)
Income from continuing operations before income taxes and equity in losses of equity method investees	471.3		304.3
Income taxes	(57.4)		(50.6)
Equity in losses of equity method investees, net of taxes	(1.0)		(0.6)
Income from continuing operations, net of taxes	412.9		253.1
Loss from discontinued operations, net of taxes	(2.5)		(22.7)
Net income	$ 410.4		$ 230.4
Earnings from continuing operations (in USD per share)	$ 0.701		$ 0.433
Loss from discontinued operations (in USD per share)	$ (0.004)		$ (0.039)
Earnings per ordinary share - basic (in USD per share)	$ 0.697		$ 0.394
Earnings from continuing operations (in USD per share)	$ 0.697		$ 0.430
Loss from discontinued operations (in USD per share)	$ (0.004)		$ (0.039)
Earnings per ordinary share - diluted (in USD per share)	$ 0.693		$ 0.391
Weighted average number of shares:
Basic (in shares)	589.1	[2]	584.3	[2]
Diluted (in shares)	592.7		588.8

[1] Research and development (“R&D”) includes intangible asset impairment charges of $nil for the three months to March 31, 2015 (2014: $166.0 million). Selling, general and administrative (“SG&A”) costs include amortization of intangible assets relating to intellectual property rights acquired of $88.3 million for the three months to March 31, 2015 (2014: $57.8 million).

[2] Excludes shares purchased by the EBT and presented by Shire as treasury stock